- Report
- June 2025
- 150 Pages
Global
From €5332EUR$5,950USD£4,575GBP
- Report
- January 2025
- 75 Pages
India
From €2913EUR$3,250USD£2,499GBP
- Report
- November 2024
- 170 Pages
Global
From €5332EUR$5,950USD£4,575GBP
- Report
- November 2024
- 160 Pages
Global
From €5332EUR$5,950USD£4,575GBP
- Report
- July 2024
- 152 Pages
Global
From €4257EUR$4,750USD£3,652GBP
- Report
- April 2023
- 111 Pages
Global
From €4257EUR$4,750USD£3,652GBP
- Report
- March 2024
- 200 Pages
Global
From €3719EUR$4,150USD£3,191GBP
- Report
- July 2025
- 211 Pages
Global
From €2241EUR$2,500USD£1,922GBP
- Report
- August 2025
- 191 Pages
Global
From €3177EUR$3,545USD£2,726GBP
€3530EUR$3,939USD£3,029GBP
- Report
- August 2025
- 193 Pages
Global
From €3177EUR$3,545USD£2,726GBP
€3530EUR$3,939USD£3,029GBP
- Report
- August 2024
- 322 Pages
Global
From €3764EUR$4,200USD£3,229GBP
- Report
- August 2025
- 199 Pages
Global
From €3177EUR$3,545USD£2,726GBP
€3530EUR$3,939USD£3,029GBP
- Report
- August 2025
- 198 Pages
Global
From €3177EUR$3,545USD£2,726GBP
€3530EUR$3,939USD£3,029GBP
- Report
- August 2025
- 184 Pages
Global
From €3177EUR$3,545USD£2,726GBP
€3530EUR$3,939USD£3,029GBP
- Report
- August 2025
- 188 Pages
Global
From €3177EUR$3,545USD£2,726GBP
€3530EUR$3,939USD£3,029GBP
- Report
- August 2025
- 188 Pages
Global
From €3177EUR$3,545USD£2,726GBP
€3530EUR$3,939USD£3,029GBP
From €3137EUR$3,500USD£2,691GBP
- Report
- July 2025
- 180 Pages
Global
From €4033EUR$4,500USD£3,460GBP
- Report
- June 2025
- 182 Pages
Global
From €4033EUR$4,500USD£3,460GBP
- Report
- January 2025
- 82 Pages
Vietnam
From €3137EUR$3,500USD£2,691GBP

Macular Degeneration is a condition that affects the central part of the retina, known as the macula, which is responsible for sharp, central vision. It is the leading cause of vision loss in people over the age of 50. Optical treatments for Macular Degeneration include laser photocoagulation, photodynamic therapy, and anti-VEGF injections. Laser photocoagulation is used to reduce the risk of further vision loss by sealing off leaking blood vessels in the macula. Photodynamic therapy is used to reduce the growth of abnormal blood vessels in the macula. Anti-VEGF injections are used to reduce the growth of abnormal blood vessels and improve vision.
Companies in the Macular Degeneration market include Novartis, Regeneron, Allergan, Genentech, and Roche. Show Less Read more